We analyzed the outcome of combining a deletion of the TGFß type 2 receptor (Tgfbr2) with deletion of the Pten tumor suppressor gene, which initiates tumorigenesis in the mouse prostate. This evidence concerns the gene TGFBR2 and neoplasm.